• Block Scientific
  • Overview
  • Opportunities
  • Territory
  • Modules
  • Signed in

Modules

Ashcroft Laboratory Partners, Inc.

Customer 6935

Account Classification
Unknown
Classification Confidence
Medium
Sites
HQ
Assigned Reps
Owen Whitfield
Website
—
Active Opportunity Count
2
Published Count
0
Revenue Base
0
Known GPBase
0
Analyzer Platforms
Medica EasyLyte
Product Groups
Medica Easylyte
Recommended Contact
Contact Enrichment Required
Backup Contact
—
Last Meaningful Activity
—
Customer Memory
AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach. Verified transaction fact: platform/product group signal is Medica EasyLyte. Verified item fact: storage requirement Room. AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
Evidence References
Candidate CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | Customer 6935 | Candidate CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841 | Customer 6935 | Order 51615 | Item 525

Opportunities (4)

Source SheetReport Run IDCandidate IDOpportunity IDOpportunity Series IDFinal DispositionAssigned RepTerritory RepSource RepCustomerCustomer IDSiteCityStateRegionAccount ClassificationClassification ConfidenceAnalyzer PlatformProduct GroupSKUItem DescriptionQuote Doc NoOrder Doc NoDeterministic SignalRevenue LowRevenue BaseRevenue HighGP LowGP BaseGP HighPriority ScoreConfidenceOpen OrderOpen QuoteSuppression StatusNext Best ActionEvidence Reference
Account Risk234b565c-29e5-43bb-9356-74dd911ab649CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33eOPP-00fd7f07efeb44ad644865feabb88a6d4a86a5f263841b752f106ec908b3c327SER-5bac9f71d31fd3bd2c2eda5505ba8c67a094ed11888d590c07b3f174ca68ae6cNeeds Validation************Ashcroft Laboratory Partners, Inc.6935HQNogalesAZSoutheastUnknownMedium——————Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $4586.25; trailing 180-day revenue $4586.25 versus $2476.92; 82 days beyond expected account order date.2293.134586.256879.38655.21310.41965.5977.01Needs ValidationFalseFalse—CONFIRM_ACCOUNTCandidate CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | Customer 6935
Overdue Reorders234b565c-29e5-43bb-9356-74dd911ab649CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841OPP-3823a474637fc73f6ecdf09f56a8b61f7654bdfff3df03dd0b382bb2e62a5d3cSER-97b4b19295e86bfe05a03ee25f81ff0c6590ce95ff3bd3961a4499d9030a2f9dNeeds Validation************Ashcroft Laboratory Partners, Inc.6935HQNogalesAZSoutheastUnknownMediumMedica EasyLyteMedica Easylyte2121[2121] Medica EasyLyte Solutions Pack, NA/K/Cl, 800mL—516156 completed purchases over 274 days; median interval 47.0 days; expected reorder 2026-05-31; High Risk by 71 days.776.281035.041293.8228.73304.98381.2266.74Needs ValidationFalseFalse—CONFIRM_ACCOUNTCandidate CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841 | Customer 6935 | Order 51615 | Item 525
Needs Validation234b565c-29e5-43bb-9356-74dd911ab649CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33eOPP-00fd7f07efeb44ad644865feabb88a6d4a86a5f263841b752f106ec908b3c327SER-5bac9f71d31fd3bd2c2eda5505ba8c67a094ed11888d590c07b3f174ca68ae6c—****——Ashcroft Laboratory Partners, Inc.6935HQ—AZ—————————Revenue and Gross-Profit Decline; 5 independent signals; trailing 90-day revenue $0.00 versus $4586.25; trailing 180-day revenue $4586.25 versus $2476.92; 82 days beyond expected account order date.—4586.25——1310.4—77.01Needs Validation———CONFIRM_ACCOUNTCandidate CAND-585313d108517ef901e6abe85a2c8ead6136881dcfa136fb91269b08d801d33e | Customer 6935
Needs Validation234b565c-29e5-43bb-9356-74dd911ab649CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841OPP-3823a474637fc73f6ecdf09f56a8b61f7654bdfff3df03dd0b382bb2e62a5d3cSER-97b4b19295e86bfe05a03ee25f81ff0c6590ce95ff3bd3961a4499d9030a2f9d—****——Ashcroft Laboratory Partners, Inc.6935HQ—AZ———Medica EasyLyte—————6 completed purchases over 274 days; median interval 47.0 days; expected reorder 2026-05-31; High Risk by 71 days.—1035.04——304.98—66.74Needs Validation———CONFIRM_ACCOUNTCandidate CAND-e4abec52ebd1e0512e23cfe9ed043169063d10ef5d3d32f5302afbb472bf9841 | Customer 6935 | Order 51615 | Item 525